ENTITY
Yunkang Group

Yunkang Group (2325 HK)

27
Analysis
Health Care • China
Yunkang Group is a leading medical operation service organization primarily engaged in providing diagnostic testing services. Its services include diagnostic outsourcing for hospitals, establishing on-site diagnostic centers for medical institution alliances, and offering personalized diagnostic testing for non-medical institutions. The company is headquartered in Guangzhou, China, and was established in 2018.
more
•30 Nov 2022 11:22

Lygend Resources & Technology IPO Trading - Tepid Subscription but Potential Upside Remains

Lygend Resources & Technology (2245 HK) raised US$470m in its Hong Kong IPO. In this note we will talk about the trading dynamics.

Logo
634 Views
Share
•18 Nov 2022 10:58

Archean Chemical Industries IPO Trading - One of the Highest Subscriptions for the Year

Archean Chemical Industries (0810406D IN) has raised about US$178m in its India IPO. In this note, we talk about the demand for the deal and the...

Logo
600 Views
Share
•17 Nov 2022 10:27

Growatt Technology Pre-IPO - Thoughts on Valuation

Growatt Technology (1833969D CH) is looking to raise about US$500m in its upcoming Hong Kong IPO. In this note, we will look at assumptions and...

Logo
587 Views
Share
bearish•Yunkang Group
•15 Nov 2022 12:08

Yungkang Group Lock-Up - Shares Benefited from a Protracted Lockdown.  Shareholders Could Monetise

Yunkang Group (2325 HK) was listed on 18th May 2022, with its six month lockup expiring on 17th November 2022. Yunkang Group is a medical operation...

Logo
488 Views
Share
•11 Nov 2022 11:36

Lygend Resources & Technology Pre-IPO Peer Comp - Peers Have Underperformed over the past Year

Lygend Resources & Technology (LR HK) is looking to raise about US$600m in its upcoming Hong Kong IPO. In this note, we look at peers and undertake...

Logo
693 Views
Share
x